Home » Medical Devices » Biologic Response Modifiers Market

Biologic Response Modifiers Market by Product Type (Interleukins, Interferons, Colony stimulating factors, Tyrosine kinase inhibitors, TNF-α, Angiogenic Inhibitors, Monoclonal antibodies, Tumor Vaccines) by Treatment Type (Cancer, Autoimmune Diseases) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies): Growth, Future Prospects, and Competitive Analysis, 2015 – 2027

Summary
Table Of Content

Makret Insights:

Biologic Response Modifiers are immunomodulators that modify immune responses. These substances can enhance or suppress the immune response. A few biological response modifiers include interferons, interleukins, colony-stimulating factors, monoclonal antibodies, and tumor necrosis, amongst others. These immunomodulators are used in cancer biotherapy to defend the body against infection, disease, and cancer. The revenue generated by the global Biologic Response Modifiers market was valued at around USD 135.3 billion in 2020 and is expected to account for USD 150.2 billion, growing at a CAGR of 5.4% during the forecast timeline.

Increasing Prevalence of Cancer Across the Globe

Biologic Response Modifiers are mainly used in the treatment of cancer. Biologic Response Modifiers help fight against cancer cells by strengthening the immune system. The increasing prevalence of cancer is fueling the demand for Biologic Response Modifiers around the globe. In 2020, around 1.8 million were found with cancer across the world. The total number of people who have cancer will reach up to 1.4% of the entire population in 2020. While, conditions in the U.S. is worst, with 5.5% of the entire population suffering from cancer as of 2020. Similarly, Australia, New Zealand, Ireland, Hungary, France, the U.K., South Korea, etc., are some countries with a notable prevalence rate of cancer.

However, high costs and lack of market penetration are holding back the growth of this industry. Emerging countries with limited access to the latest treatments and drugs, lack of healthcare infrastructure, unfavorable or absence of insurance policy, low spending power, etc., are some of the other key factors expected to contribute to the low growth rate of Biologic Response Modifiers industry.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

The outbreak of COVID 19 and its Consequences

COVID 19 has positively impacted the global Biologic Response Modifiers industry. The demand for immunity enhancers increased during the pandemic outbreak. This led to an outrageous rise in sales of biologic response modifiers medicines. Moreover, due to the demand for biological response modifiers, the market players are investing a huge amount in research and development activities. The industry players are introducing advanced medications to enhance the patients’ immunity. Such factors are propelling the demand for biologic response modifiers that will further fuel the market growth in the forecast timeline.

The U.S. Topped in Demand for Biologic Response Modifiers

The U.S. is a major force behind the growth of the Biologic Response Modifiers market. First, this can be mainly attributed to the widespread network of healthcare facilities and deep routed distribution networks of leading healthcare companies in the country. Secondly, the higher prevalence of cancer owing to changing lifestyles, the higher spending power of patients, favorable reimbursement policies, strong expenditure by the government on healthcare policies, etc., has resulted in higher demand for Biologic Response Modifiers in the U.S.

Cancer Treatment Will Held the Major Share

Cancer treatment is dominating the global Biologic Response Modifiers market with over 60% share in total revenue generation in 2020. The highest share of cancer treatment in the Biologic Response Modifiers industry can be attributed to a higher prevalence rate of cancer in the U.S. and the world. However, autoimmune diseases are also expected to hold a considerable share in the overall revenue generation of the Biologic Response Modifiers industry. More than 7% of the United States population is suffering from one type of autoimmune disease. Furthermore, there are over 80 types of diseases in the family of the autoimmune disease. With the rising incidence of the aforementioned disease, the demand for Biologic Response Modifiers is expected to gear up over the forecast period.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Retail Pharmacies Will Occupy Largest Chunk of Global Market

The Global Biologic Response Modifiers market is segmented based on distribution channels such as Retail Pharmacies, Hospital Pharmacies, and Mail Order Pharmacies. The rising establishment of organized retail players is propelling the sales of biologic response modifiers through the retail pharmacy channels. As a result, the retail pharmacy is expected to grow at a CAGR of 10.06% during the analysis period. Some of the leading players involved in this industry include Novartis, Janssen Inc., Roche Holding AG, Merck & Co., and Eli Lilly & Co. All major players are focusing on extensive R&D.

1.Preface

1.1.Report Description
1.1.1.Purpose of the Report
1.1.2.Target Audience
1.1.3.USP and Key Offerings
1.2.Research Scope
1.3.Research Methodology
1.3.1.Phase I – Secondary Research
1.3.2.Phase II – Primary Research
1.3.3.Phase III – Expert Panel Review
1.3.4.Approach Adopted
1.3.4.1.Top-Down Approach
1.3.4.2.Bottom-Up Approach
1.3.5.Assumptions
1.4.Market Segmentation

2.Executive Summary

2.1.Market Snapshot: Global Biologic Response Modifiers Market

3.Market Dynamics

3.1.Introduction
3.1.1. Global Biologic Response Modifiers Market Value, 2015-2027, (US$ Bn)
3.2.Market Dynamics
3.2.1.Key Growth Trends
3.2.2.Major Industry Challenges
3.2.3.Key Growth Pockets
3.3.Attractive Investment Proposition, 2020
3.3.1.Product Type
3.3.2.Treatment Type
3.3.3.Distribution Channel
3.3.4.Geography

4.Market Positioning of Key Players, 2020

4.1.Company market share of key players, 2020
4.2.Top 6 Players
4.3.Top 3 Players
4.4.Major Strategies Adopted by Key Players

5.COVID 19 Impact Analysis

5.1.Global Biologic Response Modifiers Market Pre Vs Post COVID 19, 2019 – 2027
5.2.Impact on Import & Export
5.3.Impact on Demand & Supply

6.North America

6.1.North America Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
6.1.1.U.S.
6.1.2.Canada
6.1.3.Mexico
6.2.North America Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
6.2.1.Overview
6.2.2.Interleukins
6.2.3.Interferons
6.2.4.Colony stimulating factors
6.2.5.Tyrosine kinase inhibitors
6.2.6.TNF-α
6.2.7.Angiogenic Inhibitors
6.2.8.Monoclonal antibodies
6.2.9.Tumor Vaccines
6.3.North America Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
6.3.1.Overview
6.3.2.Cancer
6.3.3.Autoimmune Diseases
6.4.North America Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
6.4.1.Overview
6.4.2.Hospital Pharmacies
6.4.3.Retail Pharmacies
6.4.4.Mail Order Pharmacies

7.Europe

7.1.Europe Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
7.1.1.UK
7.1.2.France
7.1.3.Germany
7.1.4.Italy
7.1.5.Russia
7.1.6.Spain
7.1.7.Belgium
7.1.8.Netherland
7.1.9.Austria
7.1.10.Sweden
7.1.11.Poland
7.1.12.Denmark
7.1.13.Switzerland
7.1.14.Rest of Europe
7.2.Europe Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
7.2.1.Overview
7.2.2.Interleukins
7.2.3.Interferons
7.2.4.Colony stimulating factors
7.2.5.Tyrosine kinase inhibitors
7.2.6.TNF-α
7.2.7.Angiogenic Inhibitors
7.2.8.Monoclonal antibodies
7.2.9.Tumor Vaccines
7.3.Europe Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
7.3.1.Overview
7.3.2.Cancer
7.3.3.Autoimmune Diseases
7.4.Europe Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
7.4.1.Overview
7.4.2.Hospital Pharmacies
7.4.3.Retail Pharmacies
7.4.4.Mail Order Pharmacies

8.Asia Pacific

8.1.Asia Pacific Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
8.1.1.China
8.1.2.Japan
8.1.3.South Korea
8.1.4.India
8.1.5.Australia
8.1.6.New Zealand
8.1.7.Taiwan
8.1.8.Southeast Asia
8.1.9.Central Asia
8.1.10.Rest of Asia Pacific
8.2.Asia Pacific Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
8.2.1.Overview
8.2.2.Interleukins
8.2.3.Interferons
8.2.4.Colony stimulating factors
8.2.5.Tyrosine kinase inhibitors
8.2.6.TNF-α
8.2.7.Angiogenic Inhibitors
8.2.8.Monoclonal antibodies
8.2.9.Tumor Vaccines
8.3.Asia Pacific Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
8.3.1.Overview
8.3.2.Cancer
8.3.3.Autoimmune Diseases
8.4.Asia Pacific Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
8.4.1.Overview
8.4.2.Hospital Pharmacies
8.4.3.Retail Pharmacies
8.4.4.Mail Order Pharmacies

9.Latin America

9.1.Latin America Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
9.1.1.Brazil
9.1.2.Argentina
9.1.3.Peru
9.1.4.Chile
9.1.5.Colombia
9.1.6.Rest of Latin America
9.2.Latin America Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
9.2.1.Overview
9.2.2.Interleukins
9.2.3.Interferons
9.2.4.Colony stimulating factors
9.2.5.Tyrosine kinase inhibitors
9.2.6.TNF-α
9.2.7.Angiogenic Inhibitors
9.2.8.Monoclonal antibodies
9.2.9.Tumor Vaccines
9.3.Latin America Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
9.3.1.Overview
9.3.2.Cancer
9.3.3.Autoimmune Diseases
9.4.Latin America Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
9.4.1.Overview
9.4.2.Hospital Pharmacies
9.4.3.Retail Pharmacies
9.4.4.Mail Order Pharmacies

10.Middle East

10.1.Middle East Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
10.1.1.UAE
10.1.2.KSA
10.1.3.Israel
10.1.4.Turkey
10.1.5.Iran
10.1.6.Rest of Middle East
10.2.Middle East Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
10.2.1.Overview
10.2.2.Interleukins
10.2.3.Interferons
10.2.4.Colony stimulating factors
10.2.5.Tyrosine kinase inhibitors
10.2.6.TNF-α
10.2.7.Angiogenic Inhibitors
10.2.8.Monoclonal antibodies
10.2.9.Tumor Vaccines
10.3.Middle East Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
10.3.1.Overview
10.3.2.Cancer
10.3.3.Autoimmune Diseases
10.4.Middle East Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
10.4.1.Overview
10.4.2.Hospital Pharmacies
10.4.3.Retail Pharmacies
10.4.4.Mail Order Pharmacies

11.Africa

11.1.Africa Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
11.1.1.South Africa
11.1.2.Egypt
11.1.3.Nigeria
11.1.4.Rest of Africa
11.2.Africa Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
11.2.1.Overview
11.2.2.Interleukins
11.2.3.Interferons
11.2.4.Colony stimulating factors
11.2.5.Tyrosine kinase inhibitors
11.2.6.TNF-α
11.2.7.Angiogenic Inhibitors
11.2.8.Monoclonal antibodies
11.2.9.Tumor Vaccines
11.3.Africa Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
11.3.1.Overview
11.3.2.Cancer
11.3.3.Autoimmune Diseases
11.4.Africa Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
11.4.1.Overview
11.4.2.Hospital Pharmacies
11.4.3.Retail Pharmacies
11.4.4.Mail Order Pharmacies

12.Global

12.1.Global Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
12.1.1.Overview
12.1.2.Interleukins
12.1.3.Interferons
12.1.4.Colony stimulating factors
12.1.5.Tyrosine kinase inhibitors
12.1.6.TNF-α
12.1.7.Angiogenic Inhibitors
12.1.8.Monoclonal antibodies
12.1.9.Tumor Vaccines
12.2.Global Biologic Response Modifiers Market, By Treatment Type, 2015-2027 (US$ Bn)
12.2.1.Overview
12.2.2.Cancer
12.2.3.Autoimmune Diseases
12.3.Global Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
12.3.1.Overview
12.3.2.Hospital Pharmacies
12.3.3.Retail Pharmacies
12.3.4.Mail Order Pharmacies

13.Company Profiles

13.1.Biogen
13.2.AbbVie Inc.
13.3.Bristol-Myers Squibb
13.4.Swedish Orphan Biovitrum
13.5.Eli Lilly &Co.
13.6.Novartis
13.7.Roche Holding AG
13.8.Merck & Co.
13.9.Janssen Inc.
13.10.Amgen

List of Figures

FIG. 1 Global Biologic Response Modifiers Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Biologic Response Modifiers Market Segmentation
FIG. 4 Global Biologic Response Modifiers Market, by Product Type, 2019 (US$ Bn)
FIG. 5 Global Biologic Response Modifiers Market, by Treatment Type, 2019 (US$ Bn)
FIG. 6 Global Biologic Response Modifiers Market, by Distribution Channel, 2019 (US$ Bn)
FIG. 7 Global Biologic Response Modifiers Market, by Geography, 2019 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Geography, 2019
FIG. 9 Global Market Positioning of Key Biologic Response Modifiers Market Manufacturers, 2019
FIG. 10 Global Biologic Response Modifiers Market Value Contribution, By Product Type, 2019 & 2027 (Value %)
FIG. 11 Global Biologic Response Modifiers Market, by Product Type 1, Value, 2015-2027 (US$ Bn)
FIG. 12 Global Biologic Response Modifiers Market, by Product Type 2, Value, 2015-2027 (US$ Bn)
FIG. 13 Global Biologic Response Modifiers Market, by Product Type 3, Value, 2015-2027 (US$ Bn )
FIG. 14 Global Biologic Response Modifiers Market, by Product Type 4, Value, 2015-2027 (US$ Bn)
FIG. 15 Global Biologic Response Modifiers Market, by Product Type 5, Value, 2015-2027 (US$ Bn)
FIG. 16 Global Biologic Response Modifiers Market Value Contribution, By Treatment Type, 2019 & 2027 (Value %)
FIG. 17 Global Biologic Response Modifiers Market, by Treatment Type 1, Value, 2015-2027 (US$ Bn)
FIG. 18 Global Biologic Response Modifiers Market, by Treatment Type 2, Value, 2015-2027 (US$ Bn)
FIG. 19 Global Biologic Response Modifiers Market Value Contribution, By Distribution Channel, 2019 & 2027 (Value %)
FIG. 20 Global Biologic Response Modifiers Market, by Distribution Channel 1, Value, 2015-2027 (US$ Bn)
FIG. 21 Global Biologic Response Modifiers Market, by Distribution Channel 2, Value, 2015-2027 (US$ Bn)
FIG. 22 Global Biologic Response Modifiers Market, by Distribution Channel 3, Value, 2015-2027 (US$ Bn)
FIG. 23 U.S. Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 24 Rest of North America Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 25 U.K. Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 26 Germany Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 27 France Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 28 Rest of Europe Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 29 Japan Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 30 China Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 31 India Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 32 Rest of Asia Pacific Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 33 Middle East & Africa Biologic Response Modifiers Market, 2015-2027 (US$ Bn)
FIG. 34 Latin America Biologic Response Modifiers Market, 2015-2027 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Biologic Response Modifiers Market
TABLE 2 Global Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 3 Global Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 4 Global Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 5 Global Biologic Response Modifiers Market, by Geography, 2015-2027 (US$ Bn)
TABLE 6 North America Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 7 North America Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 8 North America Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 9 North America Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
TABLE 10 Europe Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 11 Europe Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 12 Europe Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 13 Europe Biologic Response Modifiers Market, by Country, 2015-2027 (US$ Bn)
TABLE 14 Asia Pacific Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 15 Asia Pacific Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 16 Asia Pacific Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 17 Asia Pacific Biologic Response Modifiers Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 18 Latin America Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 19 Latin America Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 20 Latin America Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 21 Latin America Biologic Response Modifiers Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 22 Middle East Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 23 Middle East Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 24 Middle East Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 25 Africa Biologic Response Modifiers Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 26 Africa Biologic Response Modifiers Market, by Product Type, 2015-2027 (US$ Bn)
TABLE 27 Africa Biologic Response Modifiers Market, by Treatment Type, 2015-2027 (US$ Bn)
TABLE 28 Africa Biologic Response Modifiers Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 29 Africa Biologic Response Modifiers Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 30 Company 01: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Company 2: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Company 3: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Company 4.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Company 5: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Company 6: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 36 Company 7: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 37 Company 8: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 38 Company 9: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 39 Company 10: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 40 Company 11: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 41 Company 12: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 42 Company 13: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

Frequently Asked Questions

What are the consequences of COVID 19 on global Biologic Response Modifiers industry?

Unlike other industries, COVID 19 has positive impact on Biologic Response Modifiers industry. The reason being use of Biologic Response Modifiers in treatment of COVID 19 patients.

Who are the top five players in the global Biologic Response Modifiers industry?

Some of the leading players in the global BMR industry include but not limited to Novartis, Janssen Inc., Roche Holding AG, Merck & Co. and Eli Lilly & Co.

Which is the fastest growing application market for global Biologic Response Modifiers industry?

Cancer treatment is leading the global Biologic Response Modifiers industry with highest share in total revenue generation in 2020

Which is the leading regional market for global Biologic Response Modifiers industry?

U.S. is the single largest market for the Biologic Response Modifiers industry with over 25% share in total market value. Dominance of U.S. is a result of multiple factors such as higher health awareness, strong government expenditure on healthcare and ease of access to all innovative treatments owing presence of leading Biologic Response Modifiers companies in the country

What will be the CAGR (2015 – 2027) of in global Biologic Response Modifiers industry?

The global Biologic Response Modifiers market report is expected to exhibit CAGR of around 5.4% from 2015 to 2027

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –